What do systematic reviews say?

Oral NSAIDs vs placebo or no treatment

• Pain relief for outpatient hysteroscopy 2017 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 340 participants
  Low

Oral NSAIDs vs placebo or no treatment

• Pain relief for outpatient hysteroscopy 2017 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 321 participants
  Low

Oral NSAIDs vs placebo or no treatment

It is very uncertain whether oral NSAID changes vasovagal reaction compared with placebo or no treatment (very low certainty).

• Pain relief for outpatient hysteroscopy 2017 · Cochrane Headline outcomes only
  OR 0.76 [0.2, 2.94]
  1 study · 181 participants
  Very low

Intravenous ± oral steroids vs oral steroids alone

It is very uncertain whether intravenous ± oral steroids changes adverse events: thromboses compared with oral steroids alone (very low certainty).

• Interventions for minimal change disease in adults with nephrotic syndrome 2022 · Cochrane Headline outcomes only
  RR 0.5 [0.05, 4.75]
  1 study · 22 participants
  Very low

Intravenous ± oral steroids vs oral steroids alone

It is very uncertain whether intravenous ± oral steroids changes adverse events: gastrointestinal bleeding compared with oral steroids alone (very low certainty).

• Interventions for minimal change disease in adults with nephrotic syndrome 2022 · Cochrane Headline outcomes only
  RR 0.13 [0.15, 0.4]
  1 study · 18 participants
  Very low

Intravenous ± oral steroids vs oral steroids alone

It is very uncertain whether intravenous ± oral steroids changes complete remission Time frame: 2 to 28 months compared with oral steroids alone (very low certainty).

• Interventions for minimal change disease in adults with nephrotic syndrome 2022 · Cochrane Headline outcomes only
  RR 1.76 [0.17, 18.32]
  2 studies · 35 participants
  Very low

Intravenous ± oral steroids vs oral steroids alone

The review found no eligible studies for this question.

• Interventions for minimal change disease in adults with nephrotic syndrome 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intravenous ± oral steroids vs oral steroids alone

It is very uncertain whether intravenous ± oral steroids changes relapse during compared with oral steroids alone (very low certainty).

• Interventions for minimal change disease in adults with nephrotic syndrome 2022 · Cochrane Headline outcomes only
  RR 1.18 [0.65, 2.15]
  1 study · 19 participants
  Very low

Intermittent oral melatonin vs intermittent oral diazepam

• Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 60 participants
  Very low

Intermittent oral melatonin vs intermittent oral diazepam

The review found no eligible studies for this question.

• Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intermittent oral melatonin vs intermittent oral diazepam

The review found no eligible studies for this question.

• Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intermittent oral melatonin vs intermittent oral diazepam

The review found no eligible studies for this question.

• Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intermittent oral melatonin vs intermittent oral diazepam

The review found no eligible studies for this question.

• Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intermittent oral melatonin vs intermittent oral diazepam

The review found no eligible studies for this question.

• Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intermittent oral melatonin vs intermittent oral diazepam

The review found no eligible studies for this question.

• Prophylactic drug management for febrile seizures in children 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Oral + inhaled dual therapy vs oral monotherapy

It is very uncertain whether oral + inhaled dual therapy changes successful treatment of exacerbation: number of participants cured.… compared with oral monotherapy (very low certainty).

• Dual antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
  OR 0.66 [0.22, 2.01]
  1 study · 53 participants
  Very low

Oral + inhaled dual therapy vs oral monotherapy

It is very uncertain whether oral + inhaled dual therapy changes successful treatment of exacerbation: number of participants with P… compared with oral monotherapy (very low certainty).

• Dual antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
  OR 2.33 [0.66, 8.24]
  1 study · 53 participants
  Very low

Oral + inhaled dual therapy vs oral monotherapy

It is very uncertain whether oral + inhaled dual therapy changes serious adverse events. Outcome assessed on day 42 compared with oral monotherapy (very low certainty).

• Dual antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
  OR 0.48 [0.08, 2.87]
  1 study · 53 participants
  Very low

Oral + inhaled dual therapy vs oral monotherapy

It is very uncertain whether oral + inhaled dual therapy changes treatment response: relapse (day 42). Outcome assessed on day 42 compared with oral monotherapy (very low certainty).

• Dual antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
  OR 0.57 [0.12, 2.69]
  1 study · 53 participants
  Very low

Oral + inhaled dual therapy vs oral monotherapy

It is very uncertain whether oral + inhaled dual therapy changes microbiological response: eradicated. Outcome assessed on day 21 compared with oral monotherapy (very low certainty).

• Dual antibiotics for bronchiectasis 2018 · Cochrane Headline outcomes only
  OR 2.4 [0.67, 8.65]
  1 study · 49 participants
  Very low